# FDA Inspection 1120565 - LGM Pharma Solutions, LLC - January 31, 2020

Source: https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/959c277c-a14b-4450-8529-7d62cbe3505b
Source feed: FDA_Inspections

> FDA Inspection 1120565 for LGM Pharma Solutions, LLC on January 31, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120565
- Company Name: LGM Pharma Solutions, LLC
- Inspection Date: 2020-01-31
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1232056 - 2025-01-24](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/618e10e1-dad1-4647-a441-9ddec9afd566)
- [FDA Inspection 1232056 - 2025-01-24](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/f80c6bd3-5928-4b4c-ac57-81589a52ba2a)
- [FDA Inspection 1230374 - 2024-03-01](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/1d4efc76-d6cb-4820-a2a8-d28f1e3bc96a)
- [FDA Inspection 1062404 - 2018-08-17](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/1db1a1e8-3ccd-408e-9152-9b6bc20d6163)
- [FDA Inspection 1006282 - 2017-02-13](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/86257d39-a391-41fc-886e-2c7722430735)

Company: https://www.keypedia.com/companies/lgm-pharma-solutions-llc/5ee22c42-8e6e-4af9-a2b7-832e0d586f19

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c